Prescribing a biologic is much harder than traditional medicines. They cost significantly
more and they have more insurance hurdles to jump through for approval. AstraZeneca
wanted to explore different ways to increase the likelihood that a patient could get a biologic shot
on their first visit instead of waiting 60-90 days for insurance approval.
This case study requires a password. Use ‘guest’ for the name and the last 4 digits of my phone
number for the password.